Increased bioavailability of hesperetin-7-glucoside compared with hesperidin results in more efficient prevention of bone loss in adult ovariectomised rats

British Journal of Nutrition

Volumn 102, Issue 7, 2009, Pages 976-984

  Habauzit, Vronique ^a   Nielsen, Inge Lise ^b   Gil Izquierdo, Angel ^c   Trzeciakiewicz, Anna ^a   Morand, Christine ^a   Chee, Winnie ^b,d   Barron, Denis ^b   Lebecque, Patrice ^a   Davicco, Marie Jeanne ^a   Williamson, Gary ^b   Offord, Elizabeth ^b   Coxam, Véronique ^a   Horcajada, Marie Noëlle ^a  

^a INRA and University of Auvergne   (France)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c RESEARCH GROUP ON QUALITY   (Spain)

^d INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Bioavailability; Bone mineral density; Flavanones; Hesperidin; Rats

Indexed keywords

CARBOHYDRATE DERIVATIVE; CASEIN; ERIODICTYOL; FLAVONE DERIVATIVE; HESPERETIN AGLYCONE; HESPERETIN SULPHATE; HESPERIDIN; HESPERITIN 7 GLUCOSIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; BONE DENSITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; NONHUMAN; ORANGE JUICE; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PROTECTION; RAT; URINARY EXCRETION; UTERUS WEIGHT;

ANIMALS; BIOLOGICAL AVAILABILITY; BONE DENSITY; BONE REMODELING; DIETARY SUPPLEMENTS; DRUG EVALUATION, PRECLINICAL; FEMALE; FEMUR; HESPERIDIN; ORGAN SIZE; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, WISTAR; UTERUS; WEIGHT GAIN;

ANIMALIA; CITRUS; RATTUS; RATTUS NORVEGICUS;

EID: 73749085102     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509338830     Document Type: Article

References (37)

1. Horcajada-Molteni MN, Crespy V, Coxam V, et al. (2000) Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Miner Res 15, 2251-2258. (Pubitemid 30800841)
2. Muhlbauer RC, Lozano A & Reinli A (2002) Onion and a mixture of vegetables, salads, and herbs affect bone resorption in the rat by a mechanism independent of their base excess. J Bone Miner Res 17, 1230-1236.
3. Liu ZP, Li WX, Yu B, et al. (2005) Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. J Med Food 8, 14-19.
4. Setchell KDR & Lydeking-Olsen E (2003) Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78, 593S-599S.
5. Potter SM, Baum JA, Teng HY, et al. (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68, 1375S-1379S.
6. Chen YM, Ho SC, Lam SSH, et al. (2003) Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metabol 88, 4740-4747.
7. Messina M, Ho S & Alekel DL (2004) Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data. Curr Opin Clin Nutr Metab Care 7, 649-658.
8. Cassidy A, Albertazzi P, Nielsen IL, et al. (2006) Critical review of health effects of soyabean phyto-oestrogens in postmenopausal women. Proc Nutr Soc 65, 76-92.
9. Scalbert A, Morand C, Manach C, et al. (2002) Absorption and metabolism of polyphenols in the gut and impact on health. Biomed Pharmacother 56, 276-282.
10. Gil-Izquierdo A, Gil MI, Ferreres F, et al. (2001) In vitro availability of flavonoids and other phenolics in orange juice. J Agric Food Chem 49, 1035-1041.
11. Knekt P, Kumpulainen J, Jarvinen R, et al. (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76, 560-568.
12. Galati EM, Monforte MT, Kirjavainen S, et al. (1994) Biological effects of hesperidin, a citrus flavonoid. (Note I): antiinflammatory and analgesic activity. Farmaco 40, 709-712.
13. Miyake Y, Yamamoto K, Tsujihara N, et al. (1998) Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids 33, 689-695.
14. Garg A, Garg S, Zaneveld LJ, et al. (2001) Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 15, 655-669.
15. Chiba H, Uehara M, Wu J, et al. (2003) Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr 133, 1892-1897.
16. Horcajada MN, Habauzit V, Trzeciakiewicz A, et al. (2008) Hesperidin inhibits ovariectomized-induced osteopenia and shows differential effects on bone mass and strength in young and adult intact rats. J Appl Physiol 104, 648-654.
17. Deyhim F, Garica K, Lopez E, et al. (2006) Citrus juice modulates bone strength in male senescent rat model of osteoporosis. Nutrition 22, 559-563.
18. Gil-Izquierdo A, Riquelme MT, Porras I, et al. (2004) Effect of the rootstock and interstock grafted in lemon tree (Citrus limon (L.) Burm.) on the flavonoid content of lemon juice. J Agric Food Chem 52, 324-331.
19. Manach C, Morand C, Gil-Izquierdo A, et al. (2003) Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 57, 235-242.
20. Nielsen IL, Chee WS, Poulsen L, et al. (2006) Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. J Nutr 136, 404-408.
21. Graefe EU, Wittig J, Mueller S, et al. (2001) Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41, 492-499.
22. Pastoureau P, Chomel A & Bonnet J (1995) Specific evaluation of localized bone mass and bone loss in the rat using dualenergy X-ray absorptiometry subregional analysis. Osteoporos Int 5, 143-149.
23. Turner CH & Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14, 595-608.
24. Robins SP (1994) Biochemical markers for assessing skeletal growth. Eur J Clin Nutr 48, Suppl. 1, S199-S209.
25. Cook JG (1975) Factors influencing the assay of creatinine. Ann Clin Biochem 12, 219-232.
26. Matsumoto H, Ikoma Y, Sugiura M, et al. (2004) Identification and quantification of the conjugated metabolites derived from orally administered hesperidin in rat plasma. J Agric Food Chem 52, 6653-6659.
27. Kalu DN (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15, 175-191.
28. Picherit C, Chanteranne B, Bennetau-Pelissero C, et al. (2001) Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomised rat. Br J Nutr 85, 307-316.
29. Riggs BL, Khosla S, Atkinson EJ, et al. (2003) Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency. Osteoporos Int 18, 728-733.
30. Omi N & Ezawa I (1995) The effect of ovariectomy on bone metabolism in rats. Bone 17, 163S-168S.
31. Cai DJ, Zhao YD, Glasier J, et al. (2005) Comparative effect of soy protein, soy isoflavones, and 17 beta-estradiol on bone metabolism in adult ovariectomized rats. J Bone Miner Res 20, 828-839.
32. Walle UK & Walle T (2002) Induction of human UDP- glucuronosyltransferase UGT1A1 by flavonoids-structural requirements. Drug Metab Dispos 30, 564-569.
33. De Eds F, Booth AN & Jones TF (1957) Methylation and dehydroxylation of phenolic compounds by rats and rabbit. J Biol Chem 225, 615-621.
34. Silberberg M, Gil-Izquierdo A, Combaret L, et al. (2006) Flavanone metabolism in healthy and tumor-bearing rats. Biomed Pharmacother 60, 529-535.
35. Yuan L, Wagatsuma C, Sun B, et al. (2003) The role of betaglucuronidase in induction of apoptosis by genistein combined polysaccharide (GCP) in xenogeneic mice bearing human mammary cancer cells. Ann N Y Acad Sci 1010, 347-349.
36. Shimoi K & Nakayama T (2005) Glucuronidase deconjugation in inflammation. Methods Enzymol 400, 263-272.
37. Kim JY, Jung KJ, Choi JS, et al. (2006) Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell 5, 401-411.